Clinical Trial Update: Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab [NA]

View source ↗

Summary

Clinical trial assessing perfusion CT to predict outcomes in ovarian, fallopian tube, or peritoneal cancer treated with bevacizumab; the study is terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | NA | Status: TERMINATED | Results posted: 2022-09-27